Market Place
Sourcing Support
Kidney Medicine Highlights DSR 2.0 for Sequana Medical HF Program
27 Nov 2024 //
GLOBENEWSWIRE
Transparency Notification from Shareholders
26 Nov 2024 //
GLOBENEWSWIRE
Sequana Medical Announces EGM for 20 December 2024
20 Nov 2024 //
GLOBENEWSWIRE
Sequana Announces Strong 24-Month Results From POSEIDON Study
18 Nov 2024 //
GLOBENEWSWIRE
Sequana Medical Announces New Share Capital & Shares
14 Nov 2024 //
GLOBENEWSWIRE
Sequana Medical Secures Convertible Financing Of Up To EUR 1M
23 Oct 2024 //
GLOBENEWSWIRE
Sequana Medical Announces New Share Capital Amount And New Shares
21 Oct 2024 //
GLOBENEWSWIRE
Press release: Transparency Notification from Shareholders
10 Oct 2024 //
GLOBENEWSWIRE
Sequana Medical Announces Convertible Financing Up To EUR 6.1 Mn
30 Sep 2024 //
GLOBENEWSWIRE
Sequana Medical Announces H1 2024 Results & Business Update
30 Sep 2024 //
GLOBENEWSWIRE
Press release: Transparency Notification from Shareholders
09 Aug 2024 //
GLOBENEWSWIRE
Transparency Notification from Shareholders
05 Aug 2024 //
GLOBENEWSWIRE
Transparency Notification from Shareholders
01 Aug 2024 //
GLOBENEWSWIRE
Transparency Notifications from Shareholders
19 Jul 2024 //
GLOBENEWSWIRE
SEQUANA MEDICAL ANNOUNCES NEW SHARE CAPITAL AMOUNT AND NEW NUMBER OF SHARES
10 Jul 2024 //
GLOBENEWSWIRE
Sequana Medical Announces New Share Capital Amount And Number Of Shares
05 Jul 2024 //
GLOBENEWSWIRE
Sequana To Present alfapump® Safety, QoL Data At EASL 2024
06 Jun 2024 //
GLOBENEWSWIRE
Sequana Shareholder Meetings Results: Annual And Extraordinary Announced
23 May 2024 //
GLOBENEWSWIRE
Sequana Announces Positive FDA Meeting Outcome For Alfapump PMA
22 May 2024 //
GLOBENEWSWIRE
Sequana Medical announces Annual General Meeting of Shareholders on 25 May 2023
23 Apr 2024 //
GLOBENEWSWIRE
Sequana Medical Announces Annual & Extraordinary Meetings on May 23
23 Apr 2024 //
GLOBENEWSWIRE
Transparency Notifications from Shareholders
11 Apr 2024 //
GLOBENEWSWIRE
Transparency Notifications from Shareholders
08 Apr 2024 //
GLOBENEWSWIRE
Strong data from DSR® POC studies in HF Published in European Journal
03 Apr 2024 //
GLOBENEWSWIRE
Transparency Notifications from Shareholders
03 Apr 2024 //
GLOBENEWSWIRE
Sequana Medical announces 2023 Full Year Results and 2024 Outlook
28 Mar 2024 //
GLOBENEWSWIRE
Sequana Medical announces confirming dramatic improvement DSR® therapy
25 Mar 2024 //
GLOBENEWSWIRE
Sequana medical successfully raises eur 11.5 million in an equity placement
21 Mar 2024 //
GLOBENEWSWIRE
Strong data from DSR studies in heart failure accepted for presentation
27 Feb 2024 //
GLOBENEWSWIRE
Sequana Medical Announces Eur 3.0 Million Convertible Financing
08 Feb 2024 //
GLOBENEWSWIRE
Sequana Medical announces FDA acceptance for substantive review of alfapump
29 Jan 2024 //
GLOBENEWSWIRE
Transparency Notifications from Shareholders
24 Jan 2024 //
GLOBENEWSWIRE
Sequana announces DSMB approval to start Phase 1/2a study of DSR® 2.0
22 Jan 2024 //
GLOBENEWSWIRE
Transparency Notifications from Shareholders
15 Jan 2024 //
GLOBENEWSWIRE
Sequana Medical granted US CPT® III reimbursement codes for alfapump® system
03 Jan 2024 //
GLOBENEWSWIRE
Sequana Medical submits Premarket Approval application to US FDA for alfapump
28 Dec 2023 //
GLOBENEWSWIRE
Sequana Medical announces results of General Meeting of Shareholders
10 Nov 2023 //
GLOBENEWSWIRE
Sequana Medical announces additional alfapump data supporting strong profile
19 Oct 2023 //
GLOBENEWSWIRE
Sequana Medical announces initial positive data from MOJAVE
18 Oct 2023 //
GLOBENEWSWIRE
Sequana Medical announces Meeting of Shareholders on 10 November 2023
06 Oct 2023 //
GLOBENEWSWIRE
Sequana Medical Announces New Share Capital Amount And New Number Of Shares
04 Oct 2023 //
GLOBENEWSWIRE
Sequana Medical Notice of 2023 Half-year Results and Business Update
06 Sep 2023 //
GLOBENEWSWIRE
Sequana Medical announces first patient enrolled in MOJAVE
07 Jul 2023 //
GLOBENEWSWIRE
Sequana Medical announces results of Special General Meeting of Shareholders
26 Jun 2023 //
GLOBENEWSWIRE
Sequana Medical announces additional data safety, quality of life and survival
21 Jun 2023 //
GLOBENEWSWIRE
Additional data from North American pivotal alfapump® study (POSEIDON)
19 Jun 2023 //
GLOBENEWSWIRE
Sequana Medical wins Best Technology Award for alfapump® at European Awards
16 Jun 2023 //
GLOBENEWSWIRE
Sequana announces Special General Meeting of Shareholders on 26 June 2023
26 May 2023 //
GLOBENEWSWIRE
Sequana Medical announces results of Annual General Meeting of Shareholders
25 May 2023 //
GLOBENEWSWIRE
Transparency Notifications from Shareholders
15 May 2023 //
GLOBENEWSWIRE
Sequana Medical announces FDA clearance of IND application for DSRÂ
02 May 2023 //
GLOBENEWSWIRE
SEQUANA MEDICAL ANNOUNCES NEW SHARE CAPITAL AMOUNT AND NEW NUMBER OF SHARES
27 Apr 2023 //
GLOBENEWSWIRE
SEQUANA MEDICAL SUCCESSFULLY RAISES EUR 15.78 MILLION IN AN EQUITY PLACEMENT
25 Apr 2023 //
GLOBENEWSWIRE
Sequana Medical announces Annual General Meeting of Shareholders on 25 May 2023
25 Apr 2023 //
GLOBENEWSWIRE
SEQUANA LAUNCHES EQUITY PLACEMENT AND AMENDS CERTAIN EXISTING LOAN AGREEMENTS
24 Apr 2023 //
GLOBENEWSWIRE
Sequana Medical announces submission of IND application for DSR 2.0
03 Apr 2023 //
GLOBENEWSWIRE
Sequana announces additional patents for DSR in China and the United States
22 Mar 2023 //
GLOBENEWSWIRE
Sequana Medical announces positive results from CHIHUAHUA, Ph1 clinical trial
01 Mar 2023 //
GLOBENEWSWIRE
Sequana announces results of Extraordinary General Meeting of Shareholders
10 Feb 2023 //
GLOBENEWSWIRE
Transparency Notifications from Shareholders
09 Feb 2023 //
GLOBENEWSWIRE
